SB

Siva Bhaskara Naren

Active Director Director DIN 08061855
DIN 08061855 First appointment Nov 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since Nov 2021
Shareholding value •••• Premium profile

About Siva Bhaskara Naren

Data last updated:

Siva Bhaskara Naren is a Director at Saanso Pharma Private Limited (since 2023), Director at Saanso Life Sciences Private Limited (since 2022) and Director at Sunrise Biosciences Private Limited (since 2025), and holds 1 more current directorship. The companies operate in Pharma, Healthcare and Chemicals. The 3 current companies with reported revenue have a combined latest revenue of ₹47.09 Cr; the largest is Saanso Pharma Private Limited at ₹17.42 Cr (FY 2025). Earlier, Siva Bhaskara Naren was a Director at Omics Biosciences Private Limited (2022–2024) and Director at Adithya Commercials (India) Private Limited (2021–2024).

DIN 08061855
Primary Designation Director
Industry Pharma
First Appointment 10 Nov 2021
Oldest Company Age 9 yrs
Largest company Saanso Pharma Private Limited · ₹17.42 Cr (FY 2025)
Combined revenue ₹47.09 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Saanso Pharma Private Limited U01409AP2017PTC105626
Director01 Feb 20232017₹17.42 Cr (FY 2025)Active
Saanso Life Sciences Private Limited U24299TG2022PTC167988
Director03 Nov 20222022₹17.39 Cr (FY 2025)Active
Sunrise Biosciences Private Limited U46497TS2023PTC172036
Director01 Apr 20252023₹12.28 Cr (FY 2024)Active
Director20 Nov 20242024Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Omics Biosciences Private Limited U24290AP2022PTC120703
Director02 Feb 20222022₹1.59 Cr (FY 2025)Active
Director10 Nov 20212020₹28.63 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Saanso Life Sciences Private Limited
Saanso Pharma Private Limited
Sunrise Biosciences Private Limited
Saanso Nutri Sciences Private Limited
Premium access

Shareholding and investment profile for Siva Bhaskara Naren

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Siva Bhaskara Naren

Siva Bhaskara Naren currently holds 4 directorships: Saanso Pharma Private Limited (Director, since 01 Feb 2023, revenue ₹17.42 Cr (FY 2025)); Saanso Life Sciences Private Limited (Director, since 03 Nov 2022, revenue ₹17.39 Cr (FY 2025)); Sunrise Biosciences Private Limited (Director, since 01 Apr 2025, revenue ₹12.28 Cr (FY 2024)); Saanso Nutri Sciences Private Limited (Director, since 20 Nov 2024).

Siva Bhaskara Naren was first appointed on 10 Nov 2021 as Director at Adithya Commercials (India) Private Limited. The most recent appointment on record is 01 Apr 2025 at Sunrise Biosciences Private Limited.

The 3 current companies of Siva Bhaskara Naren that report revenue have a combined latest revenue of ₹47.09 Cr: Saanso Pharma Private Limited ₹17.42 Cr (FY 2025); Saanso Life Sciences Private Limited ₹17.39 Cr (FY 2025); Sunrise Biosciences Private Limited ₹12.28 Cr (FY 2024).

Siva Bhaskara Naren held 2 earlier board appointments: Omics Biosciences Private Limited (Director, 02 Feb 2022 to 29 Jan 2024); Adithya Commercials (India) Private Limited (Director, 10 Nov 2021 to 06 Feb 2024).

The current boards of Siva Bhaskara Naren's companies include Bhavna Jagdish Ahuja (Saanso Pharma Private Limited), Pruthvi Vankineni Krishna (Saanso Pharma Private Limited), Vamse Krishna Ratnakaram (Saanso Pharma Private Limited), Kakumani Ravichandra (Sunrise Biosciences Private Limited), Kiran Mai Ganta (Sunrise Biosciences Private Limited), Vanaja Sankula (Sunrise Biosciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available